As an active angel investor in the Boston tech sector, I witnessed many paths to a successful return on my invested capital. Sometimes the path is short and sweet. Other times the path is long and convoluted, but ultimately leads to a happy ending. I subscribe to the belief that as an angel investor I should be open to a variety of investment opportunities as I build a successful, early stage company portfolio. So, is it possible for an angel to make venture capital returns (e.g. 25+% IRR sustained over many years) if you don’t have access to a steady stream of potential unicorn-sized exits?
- Delta Development Team Equips Kenosha WI EMS Carry Blood to the Frontline
- NuvOx Announces Positive Results 1st Cohort Phase Ib Trial
- Tech Parks Arizona Economic Impact
- Delta Development Team Exceeds New Prehospital Blood Transfusion Standards
- Clinical Trial Confirms GammaTile Superior Tumor Control
- 2025 Brutal Biotech Investment Climate
- Delta Development Team – Introducing BloodCOMM Premium
- Special Operations Forces Blood Cooler from Delta Development
- UACI startup alumni Reglagene making impressive strides in brain cancer treatment
- Reglagene RGN6024 Cover Story August 2025 Molecular Cancer Therapeutics
